Answer
Tralokinumab is contraindicated in patients with hypersensitivity to tralokinumab or any excipient listed in section 6.1 of its product information.
Sources for this answer
- Adtralza 150 mg solution for injection in pre-filled syringeLeo Laboratories Limited · emc · SmPC §4.3 Contraindications · Version 9Document updated
Sources checked